Department of Urology, Indiana University, Indianapolis, IN, USA.
Department of Urology, University of British Columbia, Vancouver, Canada.
Eur Urol Focus. 2021 Sep;7(5):1170-1175. doi: 10.1016/j.euf.2020.11.005. Epub 2020 Dec 29.
With the heterogeneous distribution of novel surgical technologies and variable physician training, there is a need to re-evaluate contemporary outcomes of percutaneous nephrolithotomy (PCNL) for complex staghorn stones.
To evaluate contemporary outcomes of guideline-supported treatment for patients with staghorn kidney stones using single-access PCNL in multiple North American centers.
DESIGN, SETTING AND PARTICIPANTS: We performed a multi-institutional retrospective review of staghorn stones managed from January 1, 2017 to January 1, 2019, inclusive. We excluded patients with more than a single percutaneous access per renal unit and those who underwent a concomitant contralateral procedure.
Safety (Clavien-Dindo complications) and efficacy in terms of a strictly defined stone-free rate were examined for single-access PCNL performed on staghorn stones with a Guy's stone score of 3-4.
We evaluated 301 patients meeting the inclusion criteria with an average age of 57 yr (range 18-87). All stones had a Guy's stone score of 3 (36.2%) or 4 (63.8%). The mean (± standard deviation) stone burden was 191.4 ± 49.8 mm. Of the 297 patients (98.6%) who underwent computed tomography on postoperative day 1, 132 (44.4%) showed no residual stone, 111 (37.3%) had a largest fragment <4 mm, and 54 (18.2%) had a fragment ≥4 mm after primary single-access PCNL. Secondary procedures were performed in 117 patients (38.9%). Imaging at 3 mo demonstrated that 210/257 patients (82%) were stone-free. The overall complication rate was 17.9%, with 11 patients (3.7%) experiencing Clavien-Dindo grade ≥3 complications.
Single-access PCNL for complex staghorn stones is safe and effective. High stone-free rates with minimal morbidity are achievable with current techniques.
This study confirms that single-access percutaneous nephrolithotomy provides excellent outcomes in the treatment of complex kidney stones. This surgical technique has both safe and effective outcomes that are reproducible across multiple centers in North America.
由于新型手术技术的分布不均和医生培训的差异,需要重新评估采用单一通道经皮肾镜取石术(PCNL)治疗鹿角状肾结石的当代结果。
评估北美多家中心采用单一通道 PCNL 治疗鹿角状肾结石患者的指南支持治疗的当代结果。
设计、设置和参与者:我们对 2017 年 1 月 1 日至 2019 年 1 月 1 日期间接受治疗的鹿角状肾结石患者进行了多机构回顾性研究,包括这些患者。我们排除了每个肾脏单位接受超过一次经皮通道的患者和同时接受对侧手术的患者。
对于 Guy 结石评分 3-4 的鹿角状结石,采用单一通道 PCNL 治疗时,评估安全性(Clavien-Dindo 并发症)和严格定义的无结石率的疗效。
我们评估了符合纳入标准的 301 名患者,平均年龄为 57 岁(18-87 岁)。所有结石的 Guy 结石评分均为 3(36.2%)或 4(63.8%)。平均(±标准差)结石负荷为 191.4±49.8mm。在 297 名(98.6%)在术后第 1 天接受计算机断层扫描的患者中,132 名(44.4%)无残留结石,111 名(37.3%)最大碎片<4mm,54 名(18.2%)在初次单一通道 PCNL 后存在≥4mm 的碎片。117 名患者(38.9%)接受了二次手术。在 3 个月的影像学检查中,257 名患者中有 210 名(82%)无结石。总并发症发生率为 17.9%,11 名患者(3.7%)出现 Clavien-Dindo 分级≥3 级并发症。
对于复杂鹿角状结石,单一通道 PCNL 是安全有效的。采用当前技术,可实现较高的无结石率和较低的发病率。
本研究证实,单一通道经皮肾镜取石术在治疗复杂肾结石方面效果极好。这种手术技术具有安全有效的结果,在北美多个中心都具有可重复性。